Sublingual Cyclobenzaprine Approval: Expanding Options for Fibromyalgia Management
Background and Aims
Fibromyalgia (FM) is a chronic disorder characterized by widespread pain, fatigue, sleep disturbances, and cognitive issues. It is a multifactorial condition with no single definitive...
Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years
https://www.globenewswire.com/news-release/2025/08/15/3134450/28908/en/Tonix-Pharmaceuticals-Announces-FDA-Approval-of-Tonmya-cyclobenzaprine-HCl-sublingual-tablets-for-the-Treatment-of-Fibromyalgia.html
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.